Article Information
History
- December 29, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Glenda E Gray, MBBCH, FCPaed (SA),
- Shirley Collie, B.Sc.,
- Nigel Garrett, MBBS, PhD,
- Ameena Goga, MBChB, FCPaed (SA), PhD,
- Jared Champion, M.Sc.,
- Matthew Zylstra, BSc.,
- Tarylee Reddy, PhD,
- Nonhlanhla Yende, PhD,
- Ishen Seocharan, BSc,
- Azwi Takalani, MBChB,
- Ian Sanne, MBChB,
- Fatima Mayat, BPharm,
- Jacky Odhiambo, BPharm,
- Lesley Bamford, MBChB,
- Harry Moultrie, MBBCH,
- Lara Fairall, MBChB PhD,
- Linda-Gail Bekker, MBChB, FCP(SA)PhD* and
- on behalf of the Sisonke Study Team
- 1South African Medical Research Council;
- 2Discovery Health;
- 3CAPRISA;
- 4South Africa Medical Research Council;
- 5HCRISA;
- 6Right To Care;
- 7Perinatal HIV Research Unit;
- 8South African National Department of Health;
- 9NICD;
- 10The Knowledge Translation Unit, UCT;
- 11The Desmond Tutu HIV Centre
- ↵*Corresponding author: Linda-Gail Bekker, The Desmond Tutu HIV Centre, University of Cape Town, Linda-gail.bekker{at}hiv-research.org.za
Posted December 29, 2021.
Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study
